A controversy erupted over the confiscation of “substandard medicine” by the Food and Drug Administration from the Central Drug Store of Pimpri-Chinchwad Municipal Corporation located at YCM hospital. While the FDA described its action as a raid, PCMC has denied that any raid was conducted. In fact, PCMC said it had on its own taken action against “substandard medicine” while FDA has delayed its action by five months.“It was not a raid by FDA. In fact, in February this year, after a patient complaint to us that a particular medicine was proving ineffective for an ailment, we had suo motu approached the FDA. We had sent the samples of the medicine on February 23 to FDA to carry out the necessary tests regarding his efficacy for patients,” Kuldeep Jangam, Additional Municipal Commissioner, PCMC, told The Indian Express on Saturday.After giving the medicine for testing, PCMC said the FDA gave its report on July 16, which found the medicine was not of standard qualityThe PCMC said while they had already taken kept the medicine aside and blacklisting the manufacturer and the distributor, FDA officials visited the civic-run Central Drug Store located in YCM hospital on November 4. “The FDA team seized the medicine which was kept aside, away from public consumption,” Jangam said.Jangam said the value of such medicine was Rs 11,95,863 as per tender value. “However it is Rs 1.72 crore, as per FDA,” he said.In a separate statement on Saturday, PCMC said, “As soon as a complaint regarding the quality of medicines was received, the civic body followed up with the FDA for testing. After the FDA report concluded the medicines did not meet quality standards, strict action was taken against the manufacturing company and the supplier. Following a complaint received on February 14, 2026, from the Municipal Corporation’s Thergaon Hospital regarding the quality of Cap. B-Complex with Zinc (CareZinc), the PCMC sent a letter on February 23, 2026, to the FDA, requesting it to take custody of the stock of the said medicine for testing and submit a report on its suitability for use, the administration said.“Prior to that, the PCMC had restricted the use of the said medicine stock and set it aside. Accordingly, FDA officials took a sample of the medicine for testing on the same day. The medicine had been supplied through M/s. Vinayak Pharma, Pune by the manufacturer Inducare Pharmaceuticals and Research Foundation, Jejuri MIDC, Pune,” the PCMC administration said.Story continues below this adFollowing the FDA’s July 16 report, the PCMC blacklisted the manufacturing company Inducare Pharmaceuticals and Research Foundation for a period of three years. In addition, the medicine supplier M/s. Shri Vinayak Pharma, Pune was barred/restricted for a period of three years, the civic administration said.Clarifying that there is a discrepancy between that figure and the actual value of the stock of the 11 types of medicines taken into custody by the FDA, the PCMC administration said the value of the 11 medicine stocks was Rs 11,95,863. “No payment has been made by the Municipal Corporation to the supplier company for this,” the administration.“No raid was conducted by the Food and Drug Administration (FDA) regarding the medicine stock at YCM Hospital. Upon receiving a complaint about medicine quality, the Municipal Corporation took the initiative on its own and sent the medicine stock to the FDA for testing. The Municipal Corporation took this action with the objective of ensuring medicine quality and prioritizing patient safety. Therefore, the news that the FDA conducted a raid and seized medicine stock is not factual,” said Dr Laxman Gophane, health medical officer, Pimpri Chinchwad Municipal Corporation“The FDA however maintained that it had conducted a raid. ”We had indeed conducted a raid as a follow up measure after we found that the medicines given for testing were not upto the required standards,” FDA joint commissioner Girish Hukare told The Indian Express.Story continues below this adThe FDA said it will file court cases against the manufacturers who provided the poor quality medicine to PCMC.As for the delay of four months in testing, Hukare said, “Since we get medicines for testing from several places, it took time to carry out the testing of medicines supplied by PCMC. We had immediately asked the PCMC to keep aside the medicine on which complaint had been received,” he said.